Genetic contribution of HIST1H1T regulatory region alternations to human nonobstructive azoospermia-Reference-Cited by-同舟云学术

Genetic contribution of HIST1H1T regulatory region alternations to human nonobstructive azoospermia

Published:2020-05-25 Issue:7 Volume:52 Page:
ISSN:0303-4569
Container-title:Andrologia
language:en
Short-container-title:Andrologia

Author:

Mollaee Zhila¹²³,Favaedi Raha³,Jazireian Parham²³,Afsharian Parvaneh³,Mohseni Meybodi Anahita³^ORCID,Shahhoseini Maryam²³⁴^ORCID

Affiliation:

1. Department of Molecular Genetics Faculty of Basic Sciences and Advanced Technologies in Biology University of Science and Culture Tehran Iran

2. Reproductive Epidemiology Research Center Royan Institute for Reproductive Biomedicine ACECR Tehran Iran

3. Department of Genetics Reproductive Biomedicine Research Center Royan Institute for Reproductive Biomedicine ACECR Tehran Iran

4. Department of Cell and Molecular Biology School of Biology College of Science University of Tehran Tehran Iran

Funder

Royan Institute

Publisher

Wiley

Subject

Urology,Endocrinology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/and.13647

Reference19 articles.

1. A unique view on male infertility around the globe

2. Packaging paternal chromosomes with protamine

3. The human sperm epigenome and its potential role in embryonic development

4. Methods for extracting genomic DNA from whole blood samples: Current perspectives;Chacon‐Cortes D.;Journal of Biorepository Science for Applied Medicine,2014

5. Expression of the mouse testicular histone gene H1t during spermatogenesis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics of nonobstructive azoospermia;Asian Journal of Andrology;2024-09-03

2. Comparative proteomics analysis of human FFPE testicular tissues reveals new candidate biomarkers for distinction among azoospermia types and subtypes;Journal of Proteomics;2022-09

3. Epigenetic biomarkers in male infertility and its potential use in assisted reproductive technology;Epigenetics in Precision Medicine;2022